1275 related articles for article (PubMed ID: 27932874)
1. Bronchodilator response of advanced lung function parameters depending on COPD severity.
Jarenbäck L; Eriksson G; Peterson S; Ankerst J; Bjermer L; Tufvesson E
Int J Chron Obstruct Pulmon Dis; 2016; 11():2939-2950. PubMed ID: 27932874
[TBL] [Abstract][Full Text] [Related]
2. Measures of bronchodilator response of FEV
Torén K; Bake B; Olin AC; Engström G; Blomberg A; Vikgren J; Hedner J; Brandberg J; Persson HL; Sköld CM; Rosengren A; Bergström G; Janson C
Int J Chron Obstruct Pulmon Dis; 2017; 12():973-980. PubMed ID: 28356729
[TBL] [Abstract][Full Text] [Related]
3. A new approach to assess COPD by identifying lung function break-points.
Eriksson G; Jarenbäck L; Peterson S; Ankerst J; Bjermer L; Tufvesson E
Int J Chron Obstruct Pulmon Dis; 2015; 10():2193-202. PubMed ID: 26508849
[TBL] [Abstract][Full Text] [Related]
4. Acinar ventilation heterogeneity in COPD relates to diffusion capacity, resistance and reactance.
Jarenbäck L; Ankerst J; Bjermer L; Tufvesson E
Respir Med; 2016 Jan; 110():28-33. PubMed ID: 26607879
[TBL] [Abstract][Full Text] [Related]
5. Small airway dysfunction and flow and volume bronchodilator responsiveness in patients with chronic obstructive pulmonary disease.
Pisi R; Aiello M; Zanini A; Tzani P; Paleari D; Marangio E; Spanevello A; Nicolini G; Chetta A
Int J Chron Obstruct Pulmon Dis; 2015; 10():1191-7. PubMed ID: 26150710
[TBL] [Abstract][Full Text] [Related]
6. Comparison of dry powder versus nebulized beta-agonist in patients with COPD who have suboptimal peak inspiratory flow rate.
Mahler DA; Waterman LA; Ward J; Gifford AH
J Aerosol Med Pulm Drug Deliv; 2014 Apr; 27(2):103-9. PubMed ID: 23745526
[TBL] [Abstract][Full Text] [Related]
7. Bronchodilator reversibility in patients with COPD revisited: short-term reproducibility.
Pascoe S; Wu W; Zhu CQ; Singh D
Int J Chron Obstruct Pulmon Dis; 2016; 11():2035-40. PubMed ID: 27621609
[TBL] [Abstract][Full Text] [Related]
8. Detection of COPD in a high-risk population: should the diagnostic work-up include bronchodilator reversibility testing?
Kjeldgaard P; Dahl R; Løkke A; Ulrik CS
Int J Chron Obstruct Pulmon Dis; 2015; 10():407-14. PubMed ID: 25759573
[TBL] [Abstract][Full Text] [Related]
9. Triple therapy with salmeterol/fluticasone propionate 50/250 plus tiotropium bromide improve lung function versus individual treatments in moderate-to-severe Japanese COPD patients: a randomized controlled trial - Evaluation of Airway sGaw after treatment with tripLE.
Saito T; Takeda A; Hashimoto K; Kobayashi A; Hayamizu T; Hagan GW
Int J Chron Obstruct Pulmon Dis; 2015; 10():2393-404. PubMed ID: 26604737
[TBL] [Abstract][Full Text] [Related]
10. Three-minute constant rate step test for detecting exertional dyspnea relief after bronchodilation in COPD.
Borel B; Wilkinson-Maitland CA; Hamilton A; Bourbeau J; Perrault H; Jensen D; Maltais F
Int J Chron Obstruct Pulmon Dis; 2016; 11():2991-3000. PubMed ID: 27942208
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of ipratropium bromide/salbutamol sulphate administered in a hydrofluoroalkane metered-dose inhaler for the treatment of COPD.
Bhattacharya A; Bhargava S; Singh V; Talwar D; Whig J; Rebello J; Purandare S; Gogtay J
Int J Chron Obstruct Pulmon Dis; 2016; 11():1469-76. PubMed ID: 27418820
[TBL] [Abstract][Full Text] [Related]
12. Effects of Adding Tiotropium or Aclidinium as Triple Therapy Using Impulse Oscillometry in COPD.
Manoharan A; Morrison AE; Lipworth BJ
Lung; 2016 Apr; 194(2):259-66. PubMed ID: 26758884
[TBL] [Abstract][Full Text] [Related]
13. The effect of bronchodilators administered via aerochamber or a nebulizer on inspiratory lung function parameters.
Ramlal SK; Visser FJ; Hop WC; Dekhuijzen PN; Heijdra YF
Respir Med; 2013 Sep; 107(9):1393-9. PubMed ID: 23768736
[TBL] [Abstract][Full Text] [Related]
14. Daily variation in lung function in COPD patients with combined albuterol and ipratropium: results from a 4-week, randomized, crossover study.
Singh D; Zhu CQ; Sharma S; Church A; Kalberg CJ
Pulm Pharmacol Ther; 2015 Apr; 31():85-91. PubMed ID: 25197005
[TBL] [Abstract][Full Text] [Related]
15. Fixed ratio or lower limit of normal for the FEV
Wollmer P; Frantz S; Engström G; Dencker M; Löfdahl CG; Nihlén U
Clin Physiol Funct Imaging; 2017 May; 37(3):263-269. PubMed ID: 26443700
[TBL] [Abstract][Full Text] [Related]
16. Bronchodilator efficacy of 18 μg once-daily tiotropium inhalation via Discair
Yildiz P; Bayraktaroglu M; Gorgun D; Secik F
Int J Chron Obstruct Pulmon Dis; 2016; 11():2859-2867. PubMed ID: 27920513
[TBL] [Abstract][Full Text] [Related]
17. Does the mode of inhalation affect the bronchodilator response in patients with severe COPD?
Eiser NM; Phillips C; Wooler PA
Respir Med; 2001 Jun; 95(6):476-83. PubMed ID: 11421505
[TBL] [Abstract][Full Text] [Related]
18. Effects of indacaterol versus tiotropium on respiratory mechanics assessed by the forced oscillation technique in patients with chronic obstructive pulmonary disease.
Inui N; Matsushima S; Kato S; Yasui H; Kono M; Fujisawa T; Enomoto N; Nakamura Y; Toyoshima M; Suda T
Int J Chron Obstruct Pulmon Dis; 2015; 10():1139-46. PubMed ID: 26124653
[TBL] [Abstract][Full Text] [Related]
19. Combination therapy of inhaled steroids and long-acting beta2-agonists in asthma-COPD overlap syndrome.
Lee SY; Park HY; Kim EK; Lim SY; Rhee CK; Hwang YI; Oh YM; Lee SD; Park YB
Int J Chron Obstruct Pulmon Dis; 2016; 11():2797-2803. PubMed ID: 27877033
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of reversible and nonreversible COPD and asthma and COPD overlap syndrome patients: an analysis of salbutamol Easyhaler data.
Müller V; Gálffy G; Orosz M; Kováts Z; Odler B; Selroos O; Tamási L
Int J Chron Obstruct Pulmon Dis; 2016; 11():93-101. PubMed ID: 26834466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
